Skip to content
AnalystLens

Charles River Laboratories International 8-K Report, Executive Changes (Jan 16, 2024)

Reports
Leadership Changes
Filing Date
Filed January 16, 2024
Period End
January 9, 2024
Security
CRL
In the record · 2016–202610-K1110-Q338-K117

CRL filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 117 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Apr ’18Apr ’18
  2. Material agreement8-K · Oct ’19Oct ’19
  3. Leadership change8-K · Mar ’22Mar ’22
  4. Leadership change8-K · May ’26May ’26

Summary

Summary of the 8-K filed January 16, 2024. Cited figures are marked; the original filing is the authoritative source.

Charles River Laboratories International, Inc. (CRL) filed this Current Report under Item 5.02, which covers departures and appointments of certain officers.

The Company announced on January 9 that William D. Barbo, Corporate Executive Vice President and Chief Commercial Officer, will retire at the end of 2024 after a 42-year career with the Company. Until then, he will continue as Executive Vice President and strategic advisor to ensure a smooth transition of his responsibilities.

In connection with the planned retirement, Kristen Eisenhauer is assuming the role of Senior Vice President, Chief Commercial Officer. Ms. Eisenhauer has been with the Company for 20 years and has held leadership roles spanning operations management, client services, sales, and marketing. Most recently, she served as Corporate Senior Vice President, Safety Assessment Customer Excellence.

For investors, the filing is a planned leadership succession in the commercial function. It discloses no financial results, guidance, or compensation terms for either executive.

Key Highlights

  1. William D. Barbo, Corporate Executive Vice President and Chief Commercial Officer, will retire at the end of 2024 after a 42-year career with the Company.
  2. Barbo will serve as Executive Vice President and strategic advisor until his retirement to support a smooth transition.
  3. Kristen Eisenhauer is assuming the role of Senior Vice President, Chief Commercial Officer.
  4. Eisenhauer has been with the Company for 20 years and has held roles in operations management, client services, sales, and marketing.
  5. Eisenhauer most recently served as Corporate Senior Vice President, Safety Assessment Customer Excellence.
  6. The filing does not disclose any financial results, guidance, or compensation arrangements related to these changes.

Frequently Asked Questions

  1. Who is leaving the commercial leadership role at Charles River Laboratories?

    William D. Barbo, Corporate Executive Vice President and Chief Commercial Officer, will retire at the end of 2024 after a 42-year career with the Company.

  2. Will Barbo leave the company immediately?

    No. Until he retires, Barbo will continue as Executive Vice President and strategic advisor to ensure a smooth transition of his responsibilities.

  3. Who is replacing Barbo as Chief Commercial Officer?

    Kristen Eisenhauer is assuming the role of Senior Vice President, Chief Commercial Officer.

  4. What is Eisenhauer's background?

    Eisenhauer has been with the Company for 20 years and has held leadership roles in operations management, client services, sales, and marketing. Most recently, she was Corporate Senior Vice President, Safety Assessment Customer Excellence.

  5. Does the filing disclose any financial impact of these changes?

    No. The filing does not state any financial results, guidance, or compensation terms associated with the leadership changes.